Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05269667
Status:
TERMINATED
Last Update Posted:
2023-11-08
First Post:
2022-02-15
Brief Title:
A Study In Neuromyelitis Optica Spectrum Disorder NMOSD With Satralizumab As An Intervention
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| NMOSD |
| Neuromyelitis Optica Spectrum Disorder |
Keywords: